Flora Growth to implement 1-for-39 share consolidation

Published 31/07/2025, 13:18
Flora Growth to implement 1-for-39 share consolidation

FORT LAUDERDALE - Flora Growth Corp. (NASDAQ:FLGC) announced Thursday it will implement a 1-for-39 share consolidation of its issued and outstanding common shares, effective August 3, 2025, at 5:00 p.m. Eastern Time. The micro-cap company, currently valued at $14.21 million, has seen its shares decline nearly 39% year-to-date, according to InvestingPro data.

The company’s common shares are expected to resume trading on a post-consolidation basis on the Nasdaq Capital Market when markets open on August 4, while continuing to trade under the existing ticker "FLGC."

According to the company’s press release statement, the primary purpose of the share consolidation is to increase the bid price of Flora Growth’s common shares to regain compliance with Nasdaq Capital Market’s continued listing requirements.

The consolidation was previously approved by shareholders at the annual and special meeting held on June 30, 2025, authorizing the board to implement a ratio ranging from 1-for-10 up to 1-for-100 within one year of approval. Investors should note that the company’s next earnings report is scheduled for August 19, 2025.

As a result of the consolidation, every 39 common shares will automatically be reclassified into one new common share. Proportionate adjustments will be made to the per share exercise price and number of common shares issuable upon exercise or conversion of outstanding equity awards, convertible securities and warrants.

No fractional shares will be issued, with shareholders entitled to receive fractional shares automatically receiving an additional fraction to round up to the next whole share.

The new CUSIP number for the common shares will be 339764300 and the new ISIN will be CA3397643006 as of the effective date.

In other recent news, Flora Growth Corp. held its 2025 Annual and Special Meeting, where shareholders approved several key proposals. Among the approvals was an amendment to the company’s 2022 Incentive Compensation Plan, increasing the number of common shares reserved for issuance from 2,500,000 to 4,500,000. This amendment had already received board authorization in April, pending shareholder approval. In addition to these corporate governance changes, Flora Growth has made a strategic investment in digital assets. The company allocated $1 million to various cryptocurrencies, including Ethereum, Solana, Sui, and Ripple. This move reflects a diversification strategy, with $400,000 each invested in Ethereum and Solana, and $100,000 each in Sui and Ripple. Flora Growth’s investment in these cryptocurrencies highlights its interest in technological innovation and potential long-term adoption. These developments showcase the company’s evolving strategic directions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.